Alvotech (NasdaqGM:ALVO) Valuation Check After New $100 Million GoldenTree Term Loan for Biosimilar Growth [Yahoo! Finance]
Alvotech - Ordinary Shares (ALVO)
Company Research
Source: Yahoo! Finance
See our latest analysis for Alvotech. Despite this vote of confidence from lenders, Alvotech's share price has had a tough run, with a 90 day share price return of minus 41.72 percent and a 1 year total shareholder return of minus 62.29 percent. This suggests sentiment remains cautious even as management shores up liquidity for future growth. If this kind of financing pivot has you rethinking your exposure to healthcare, it could be a good moment to explore other specialist opportunities across healthcare stocks With the stock trading well below analyst targets despite double digit revenue and profit growth, investors now face a key question: is Alvotech a mispriced biosimilar contender, or is the market already discounting its future pipeline upside? With Alvotech last closing at $5.00 against a narrative fair value near $22, the current market price implies a steep discount to projected earnings power. In order for the above numbers to justify the analysts price target, t
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ALVO
News
- ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire
- Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOPR Newswire
- ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock CrashPR Newswire
- ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire
- Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOPR Newswire
ALVO
Earnings
- 11/12/25 - Beat
ALVO
Sec Filings
- 1/7/26 - Form 6-K
- 1/7/26 - Form 6-K
- 1/6/26 - Form 6-K
- ALVO's page on the SEC website